[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@ohadhammer Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::4733861002.png) @ohadhammer Ohad Hammer

Ohad Hammer posts on X about strong, finish, $zlab, $gmab the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::4733861002/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4733861002/c:line/m:interactions.svg)

- X Week XXXXXX +817%
- X Month XXXXXX -XX%
- X Months XXXXXXX +47%
- X Year XXXXXXX -XX%

### Mentions: X [#](/creator/twitter::4733861002/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4733861002/c:line/m:posts_active.svg)

- X Month X -XX%
- X Months XX +48%
- X Year XX no change

### Followers: XXXXX [#](/creator/twitter::4733861002/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4733861002/c:line/m:followers.svg)

- X Week XXXXX +0.46%
- X Month XXXXX +1.50%
- X Months XXXXX +8.30%
- X Year XXXXX +15%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::4733861002/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4733861002/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[strong](/topic/strong), [finish](/topic/finish), [$zlab](/topic/$zlab), [$gmab](/topic/$gmab), [$lly](/topic/$lly), [$8750t](/topic/$8750t), [$llys](/topic/$llys), [$nvos](/topic/$nvos), [just a](/topic/just-a), [matter](/topic/matter)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/$lly) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Mineralys Therapeutics, Inc. Common Stock (MLYS)](/topic/$mlys) [NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Vera Therapeutics, Inc. Class A Common Stock (VERA)](/topic/$vera) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr)
### Top Social Posts
Top posts by engagements in the last XX hours

"Similar story in SCLC with ADCs targeting B7H3 DLL3 SEZ6 all reporting strong efficacy. 15+ programs in the clinic most will finish the race empty handed (Table from Jefferies' note on $ZLAB)"  
[X Link](https://x.com/ohadhammer/status/1980884998031859839)  2025-10-22T06:32Z 8028 followers, 17.5K engagements


"Cross trial comparison of next gen obesity drugs (table from JPM). $LLY's GGG (GLP1+GIP+ glucagon)vs $NVO's GA (GLP1+amylin). Both lead to XX% weight loss GGG looks more effective but GA is better tolerated so perhaps just a matter of dose intensity. When comparing these results to existing obesity drugs it seems like the appetite hormone class has potentially reached its ceiling"  
[X Link](https://x.com/ohadhammer/status/2000497056432128470)  2025-12-15T09:24Z 8040 followers, 21.1K engagements


"Interesting results from RBC's survey (50 funds) about M&A candidates sheds light on market perception (not necessarily reflects pharma's priorities). With the exception of $RVMD oncology companies look out of favor. Cardio/met seems to be the hottest sector ( $MLYS $NAMS $CYTK $MDGL $GPCR) with multiple popular I&I names ( $ABVX $VERA $KYMR)"  
[X Link](https://x.com/ohadhammer/status/2001656597202731233)  2025-12-18T14:11Z 8040 followers, 21.1K engagements